The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bombardier, C., Laine, L., Reicin, A., Shapiro, D., Burgos-Vargas, R., Davis, B., Day, R., Ferraz, M. B., Hawkey, C. J., Hochberg, M. C., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011233432103 · Cited by 4,027
Dendritic cells as therapeutic vaccines against cancer
Banchereau, J., & Palucka, A. K. (2005) · Nature Reviews Immunology · doi:10.1038/nri1592 · Cited by 1,204
Serhan, C. N., Clish, C. B., Brannon, J., Colgan, S. P., Chiang, N., & Gronert, K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.8.1197 · Cited by 1,189
Prostaglandins as modulators of immunity
Harris, S. G., Padilla, J., Koumas, L., Ray, D., & Phipps, R. P. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(01)02154-8 · Cited by 1,180
Hirai, H., Tanaka, K., Yoshie, O., Ogawa, K., Kenmotsu, K., Takamori, Y., Ichimasa, M., Sugamura, K., Nakamura, M., Takano, S., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.255 · Cited by 1,099
Celecoxib for the Prevention of Sporadic Colorectal Adenomas
Bertagnolli, M. M., Eagle, C. J., Zauber, A. G., Redston, M., Solomon, S. D., Kim, K., Tang, J., Rosenstein, R. B., Wittes, J., Corle, D., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061355 · Cited by 1,048
A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis
Yokomizo, T., Izumi, T., Chang, K., Takuwa, Y., & Shimizu, T. (1997) · Nature · doi:10.1038/42506 · Cited by 971
Characterization of the human cysteinyl leukotriene CysLT1 receptor
Lynch, K. R., O'Neill, G. P., Liu, Q., Im, D.-S., Sawyer, N., Metters, K. M., Coulombe, N., Abramovitz, M., Figueroa, D. J., Zeng, Z., et al. (1999) · Nature · doi:10.1038/21658 · Cited by 965
Treatment of Asthma with Drugs Modifying the Leukotriene Pathway
Drazen, J. M., Israel, E., & O'Byrne, P. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901213400306 · Cited by 820
Overexpression of Cyclooxygenase-2 Is Sufficient to Induce Tumorigenesis in Transgenic Mice
Liu, C. H., Chang, S.-H., Narko, K., Trifan, O. C., Wu, M.-T., Smith, E., Haudenschild, C., Lane, T. F., & Hla, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010787200 · Cited by 807
Genetic and pharmacological analysis of prostanoid receptor function
Narumiya, S., & FitzGerald, G. A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13455 · Cited by 568
A Second Leukotriene B4 Receptor, Blt2
Yokomizo, T., Kato, K., Terawaki, K., Izumi, T., & Shimizu, T. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.421 · Cited by 538
Anti-Inflammatory and Proresolving Lipid Mediators
Serhan, C. N., Yacoubian, S., & Yang, R. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.151409 · Cited by 507
Scandella, E., Men, Y., Gillessen, S., Förster, R., & Groettrup, M. (2002) · Blood · doi:10.1182/blood-2001-11-0017 · Cited by 500
Robbiani, D. F., Finch, R. A., Jäger, D., Muller, W. A., Sartorelli, A. C., & Randolph, G. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00179-3 · Cited by 454
Cyclooxygenase-2: a novel target for cancer chemotherapy?
Dempke, W., Rie, C., Grothey, A., & Schmoll, H.-J. (2001) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s004320000225 · Cited by 419
Wada, M., DeLong, C. J., Hong, Y. H., Rieke, C. J., Song, I., Sidhu, R. S., Yuan, C., Warnock, M., Schmaier, A. H., Yokoyama, C., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703169200 · Cited by 400
Dendritic cell maturation by innate lymphocytes
Münz, C., Steinman, R. M., & Fujii, S.-I. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050810 · Cited by 393
Prostanoids and prostanoid receptors in signal transduction
Bos, C. L., Richel, D. J., Ritsema, T., Peppelenbosch, M. P., & Versteeg, H. H. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2003.08.006 · Cited by 387
Harizi, H., Juzan, M., Pitard, V., Moreau, J.-F., & Gualde, N. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.5.2255 · Cited by 384
Self-citationKaliński, P., Schuitemaker, J. H. N., Hilkens, C. M. U., & Kapsenberg, M. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.2804 · Cited by 371
Kaliński, P., Vieira, P. L., Schuitemaker, J. H. N., de Jong, E. C., & Kapsenberg, M. L. (2001) · Blood · doi:10.1182/blood.v97.11.3466 · Cited by 362
Luft, T., Jefford, M., Luetjens, P., Toy, T., Hochrein, H., Masterman, K.-A., Maliszewski, C., Shortman, K., Cebon, J., & Maraskovsky, E. (2002) · Blood · doi:10.1182/blood-2001-12-0360 · Cited by 358
Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A4
Levy, B. D., De Sanctis, G. T., Devchand, P. R., Kim, E., Ackerman, K., Schmidt, B. A., Szczeklik, W., Drazen, J. M., & Serhan, C. N. (2002) · Nature Medicine · doi:10.1038/nm748 · Cited by 352
Tiano, H. F., Loftin, C. D., Akunda, J., Lee, C. A., Spalding, J. W., Sessoms, A. R., Dunson, D. B., Rogan, E. G., Morham, S. G., Smart, R. C., et al. (2002) · PubMed · Cited by 344
Wang, D., Wang, H., Shi, Q., Katkuri, S., Walhi, W., Desvergne, B., Das, S. K., Dey, S. K., & DuBois, R. N. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.011 · Cited by 340
Eicosanoids in Inflammation: Biosynthesis, Pharmacology, and Therapeutic Frontiers
Khanapure, S., Garvey, D., Janero, D., & Gordon Letts, L. (2007) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607779941314 · Cited by 333
Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor
Monneret, G., Gravel, S., Diamond, M., Rokach, J., & Powell, W. S. (2001) · Blood · doi:10.1182/blood.v98.6.1942 · Cited by 326
Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling
Holgate, S. T., Peters-Golden, M., Panettieri, R. A., & Henderson, W. R. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.25 · Cited by 318
Kabashima, K., Sakata, D., Nagamachi, M., Miyachi, Y., Inaba, K., & Narumiya, S. (2003) · Nature Medicine · doi:10.1038/nm872 · Cited by 316
Kim, N. D., Chou, R. C., Seung, E., Tager, A. M., & Luster, A. D. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052349 · Cited by 273
Aliberti, J., Hieny, S., Reis e Sousa, C., Serhan, C. N., & Sher, A. (2002) · Nature Immunology · doi:10.1038/ni745 · Cited by 258
Tumor cyclooxygenase 2-dependent suppression of dendritic cell function.
Sharma, S. P., Stolina, M., Yang, S.-C., Baratelli, F. E., Lin, J. F.-H., Atianzar, K., Luo, J., Zhu, L., Lin, Y., Huang, M., et al. (2003) · PubMed · Cited by 255
Mast cells and eicosanoid mediators: a system of reciprocal paracrine and autocrine regulation
Boyce, J. A. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00512.x · Cited by 254
Yang, L., Yamagata, N., Yadav, R., Brandon, S., Courtney, R. L., Morrow, J. D., Shyr, Y., Boothby, M., Joyce, S., Carbone, D. P., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16492 · Cited by 250
Nuclear localization of prostaglandin E 2 receptors
Bhattacharya, M., Peri, K. G., Almazan, G., Ribeiro-da-Silva, A., Shichi, H., Durocher, Y., Abramovitz, M., Hou, X., Varma, D. R., & Chemtob, S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15792 · Cited by 240
Anti-inflammatory circuitry: Lipoxin, aspirin-triggered lipoxins and their receptor ALX
Chiang, N., Arita, M., & Serhan, C. N. (2005) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.05.003 · Cited by 239
T-cell trafficking in asthma: lipid mediators grease the way
Luster, A. D., & Tager, A. M. (2004) · Nature Reviews Immunology · doi:10.1038/nri1438 · Cited by 213
Avis, I., Hong, S. H., Martínez, A., Moody, T., Choi, Y. H., Trepel, J., Das, R., Jett, M., & Mulshine, J. L. (2001) · The FASEB Journal · doi:10.1096/fj.00-0866fje · Cited by 202
Edelman, M. J., Watson, D., Wang, X., Morrison, C., Kratzke, R. A., Jewell, S., Hodgson, L., Mauer, A. M., Gajra, A., Masters, G. A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.8081 · Cited by 194
Öhd, J. F., Nielsen, C. K., Campbell, J., Landberg, G., Löfberg, H., & Sjölander, A. (2003) · Gastroenterology · doi:10.1053/gast.2003.50011 · Cited by 191
Prostaglandin E2 primes naive T cells for the production of anti‐inflammatory cytokines
Demeure, C. E., Yang, L., Desjardins, C., Raynauld, P., & Delespesse, G. (1997) · European Journal of Immunology · doi:10.1002/eji.1830271254 · Cited by 175
Shinomiya, S., Naraba, H., Ueno, A., Utsunomiya, I., Maruyama, T., Ohuchida, S., Ushikubi, F., Yuki, K., Narumiya, S., Sugimoto, Y., et al. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00586-x · Cited by 172
Prostaglandin E2 modulates dendritic cell function via EP2 and EP4 receptor subtypes
Harizi, H., Grosset, C., & Gualde, N. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.1002483 · Cited by 172
Self-citationPockaj, B. A., Basu, G. D., Pathangey, L. B., Gray, R. J., Hernandez, J. L., Gendler, S. J., & Mukherjee, P. (2004) · Annals of Surgical Oncology · doi:10.1245/aso.2004.05.027 · Cited by 168
Fedyk, E. R., & Phipps, R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10978 · Cited by 163
COX-2 inhibition and lung cancer
Sandler, A. B., & Dubinett, S. M. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.03.045 · Cited by 150
Takaku, K., Sonoshita, M., Sasaki, N., Uozumi, N., Doi, Y., Shimizu, T., & Taketo, M. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000586200 · Cited by 141
Pradono, P., Tazawa, R., Maemondo, M., Tanaka, M., Usui, K., Saijo, Y., Hagiwara, K., & Nukiwa, T. (2002) · PubMed · Cited by 138
Prostaglandin E2 inhibits TNF production in murine bone marrow-derived dendritic cells
Vassiliou, E. K., Jing, H., & Ganea, D. (2003) · Cellular Immunology · doi:10.1016/s0008-8749(03)00158-8 · Cited by 132
Pro-inflammatory prostaglandins and progression of colorectal cancer
Wang, D., & DuBois, R. N. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.004 · Cited by 130
Involvement of leukotriene B4 in arthritis models
Tsuji, F., Oki, K., Fujisawa, K., Okahara, A., Horiuchi, M., & Mita, S. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00556-6 · Cited by 130
Antileukotriene Drugs: Clinical Application, Effectiveness and Safety
Riccioni, G., Bucciarelli, T., Mancini, B., Ilio, C. D., & D’Orazio, N. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707781368522 · Cited by 126
Prostaglandin E2 Suppresses NK Activity In Vivo and Promotes Postoperative Tumor Metastasis in Rats
Yakar, I., Melamed, R., Shakhar, G., Shakhar, K., Rosenne, E., Abudarham, N., Page, G. G., & Ben‐Eliyahu, S. (2003) · Annals of Surgical Oncology · doi:10.1245/aso.2003.08.017 · Cited by 124
Walker, W., & Rotondo, D. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01810.x · Cited by 121
Harizi, H., & Gualde, N. (2005) · Tissue Antigens · doi:10.1111/j.1399-0039.2005.00394.x · Cited by 121
Self-citationAkaogi, J., Nozaki, T., Satoh, M., & Yamada, H. (2006) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153006779025711 · Cited by 108
Harizi, H., Juzan, M., Grosset, C. F., Rashedi, M., & Gualde, N. (2001) · Cellular Immunology · doi:10.1006/cimm.2001.1785 · Cited by 106
Self-citationFeldon, S. E., O’Loughlin, C. W., Ray, D. M., et al. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060434 · Cited by 100
Harizi, H., Juzan, M., Moreau, J., & Gualde, N. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.139 · Cited by 93
Self-citationBryn, T., Yaqub, S., Mahic, M., Henjum, K., Aandahl, E. M., & Taskén, K. (2007) · International Immunology · doi:10.1093/intimm/dxm134 · Cited by 87
Levin, G., Duffin, K. L., Obukowicz, M. G., HUMMERT, S. L., Fujiwara, H., Needleman, P., & Raz, A. (2002) · Biochemical Journal · doi:10.1042/bj20011798 · Cited by 87
Theiner, G., Gessner, A., & Lutz, M. B. (2006) · Immunobiology · doi:10.1016/j.imbio.2006.05.020 · Cited by 75
Harizi, H., & Gualde, N. (2004) · Cellular Immunology · doi:10.1016/j.cellimm.2004.04.003 · Cited by 70
Self-citationProstanoids and their receptors that modulate dendritic cell‐mediated immunity
Gualde, N., & Harizi, H. (2004) · Immunology and Cell Biology · doi:10.1111/j.0818-9641.2004.01251.x · Cited by 69
Self-citationWhittaker, D. S., Bahjat, K. S., Moldawer, L. L., & Clare-Salzler, M. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.8.4298 · Cited by 68
Hematopoietic Prostaglandin D Synthase Suppresses Intestinal Adenomas in Apc Min/+ Mice
Park, J. M., Kanaoka, Y., Eguchi, N., Aritake, K., Grujic, S., Materi, A. M., Buslon, V. S., Tippin, B. L., Kwong, A. M., SALIDO, E. C., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-05-3767 · Cited by 68
Prostaglandin E receptor subtype EP1 deficiency inhibits colon cancer development
Kawamori, T. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh322 · Cited by 64
Activation of nuclear receptors by prostaglandins
Ide, T., Egan, K. M., Bell, L. C., & FitzGerald, G. A. (2003) · Thrombosis Research · doi:10.1016/s0049-3848(03)00418-3 · Cited by 63
Prostaglandin D2 Suppresses Human NK Cell Function via Signaling through D Prostanoid Receptor
Chen, Y., PERUSSIA, B., & Campbell, K. S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.2766 · Cited by 60
Paruchuri, S. M., Mezhybovska, M., Juhas, M., & Sjölander, A. (2006) · Oncogene · doi:10.1038/sj.onc.1209666 · Cited by 57
Cyclooxygenase-2 in Lung Cancer
Dubinett, S. M., Sharma, S. P., Huang, M., Dohadwala, M., Pǒld, M., & Mao, J. T. (2003) · KARGER eBooks · doi:10.1159/000071371 · Cited by 56
Shen, D., Deng, C., & Zhang, M. (2007) · Postgraduate Medical Journal · doi:10.1136/pmj.2006.052761 · Cited by 54
Harizi, H., & Gualde, N. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2002.0383 · Cited by 48
Self-citationProstaglandin E2 and cAMP promote B lymphocyte class switching to IgG1
Roper, R. L., Graf, B. A., & Phipps, R. P. (2002) · Immunology Letters · doi:10.1016/s0165-2478(02)00185-2 · Cited by 47
Józefowski, S., Bobek, M., & Marcinkiewicz, J. (2003) · International Immunopharmacology · doi:10.1016/s1567-5769(03)00072-9 · Cited by 47
Leukotriene Receptors: Crucial Components in Vascular Inflammation
Bäck, M. (2007) · The Scientific World JOURNAL · doi:10.1100/tsw.2007.187 · Cited by 47
PGE2-mediated inhibition of T cell p59fyn is independent of cAMP
Choudhry, M. A., Ahmed, Z., & Sayeed, M. M. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.277.2.c302 · Cited by 43
Leukotrienes modulate cytokine release from dendritic cells
Józefowski, S., Biedroń, R., Bobek, M., & Marcinkiewicz, J. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02241.x · Cited by 43
Fogel‐Petrovic, M., Long, J. A., Knight, D. A., Thompson, P. J., & Upham, J. W. (2004) · Immunology and Cell Biology · doi:10.1111/j.1440-1711.2004.01213.x · Cited by 39
Robak, P. J., Smolewski, P., & Robak, T. (2008) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190802108854 · Cited by 32
Lee, I. Y., Cho, W., Kim, J., Park, C.-S., & Choe, J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1390 · Cited by 31
Bernard, M. P., & Phipps, R. P. (2007) · Clinical Immunology · doi:10.1016/j.clim.2007.07.006 · Cited by 29
PGE2suppresses mitogen-induced Ca2+mobilization in T cells
Choudhry, M. A., Hockberger, P. E., & Sayeed, M. M. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.277.6.r1741 · Cited by 26
Levy, B. D., & Serhan, C. N. (2003) · Drugs of today · doi:10.1358/dot.2003.39.5.740217 · Cited by 24
Liu, A., Claesson, H., Mahshid, Y., Klein, G., & Klein, E. (2007) · Blood · doi:10.1182/blood-2007-08-102319 · Cited by 19
Differential regulation of cyclooxygenase 2 expression by small GTPases Ras, Rac1, and RhoA
Chang, Y. E., Putzer, K., Ren, L., Kaboord, B. J., Chance, T. W., Qoronfleh, M. W., & Jakobi, R. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20568 · Cited by 18
Eicosanoids: an emerging role in dendritic cell biology.
Harizi, H., & Gualde, N. (2004) · PubMed · Cited by 12
Self-citationBurgermeister, E., Endl, J., & Scheuer, W. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01492-4 · Cited by 10
Wan, K.-S., & Wu, W. (2008) · PubMed · Cited by 6
Novel Strategies for the Treatment of Lung Cancer: Modulation of Eicosanoids
Backlund, M. G., Amann, J. M., & Johnson, D. H. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.9583 · Cited by 5
Cited by
CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4
Liao, P., Wang, W., Wang, W., Kryczek, I., Li, X., Bian, Y., Sell, A., Wei, S., Grove, S., Johnson, J. K., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.02.003 · Cited by 912
Health Implications of High Dietary Omega-6 Polyunsaturated Fatty Acids
Patterson, E., Wall, R., Fitzgerald, G. F., Ross, R. P., & Stanton, C. (2012) · Journal of Nutrition and Metabolism · doi:10.1155/2012/539426 · Cited by 883
Exosomal lipid composition and the role of ether lipids and phosphoinositides in exosome biology
Skotland, T., Hessvik, N. P., Sandvig, K., & Llorente, A. (2019) · Journal of Lipid Research · doi:10.1194/jlr.r084343 · Cited by 730
The senescence-associated secretory phenotype and its regulation
Lopes-Paciencia, S., Saint-Germain, E., Rowell, M.-C., Ruiz, A. F., Kalegari, P., & Ferbeyre, G. (2019) · Cytokine · doi:10.1016/j.cyto.2019.01.013 · Cited by 601
5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease
Rådmark, O., Werz, O., Steinhilber, D., & Samuelsson, B. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.08.012 · Cited by 502
Metadata
- Authors
- Harizi, H., Corcuff, J.-B., & Gualde, N.
- Venue
- Trends in Molecular Medicine
- Publisher
- Elsevier BV
- Published
- 2008-10
- Volume
- 14
- Issue
- 10
- Pages
- 461-469
- ISSN
- 1471-4914 (ISSN-L)
- OpenAlex
- W2123869725
- Cited by
- 636
- References
- 91
- FWCI
- 2.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.